Form 4: New Enterprise Associates Acquires Warrants in NeueHealth, Inc.

Sentiment:

SEC Form 4


New Enterprise Associates 15, L.P. reports the acquisition of warrants to purchase 123,729 shares of NeueHealth, Inc. common stock.

Summary

  • New Enterprise Associates 15, L.P. filed a Form 4 disclosing the acquisition of warrants for NeueHealth, Inc. common stock on April 8, 2024.
  • The warrants, exercisable after issuance and prior to the fifth anniversary of the Closing Date, allow the purchase of 123,729 shares.
  • The warrants are issued pursuant to a Warrantholders Agreement and a Credit Agreement.
  • NEA Partners 15, L.P., NEA 15 GP, LLC, and individual managers of NEA 15 GP indirectly hold the securities.
  • The Indirect Reporting Persons disclaim beneficial ownership of the securities held by NEA 15 in which they have no pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Future Outlook

The warrants will be exercisable at any time after issuance and prior to the close of business on the fifth anniversary of the Closing Date.

Management Comments

  • The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Indirect Reporting Persons have no pecuniary interest.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders (10% owners) of a publicly traded company buy or sell shares, or in this case, acquire warrants. This filing indicates changes in beneficial ownership and provides transparency to the market.

Stakeholder Impact

  • The acquisition of warrants by a major shareholder could be viewed positively by other shareholders, signaling confidence in the company's future.

Key Dates

DateDescription
08/04/2023Date of the Credit Agreement between the Issuer and the lenders thereto.
10/02/2023Date of Incremental Amendment No. 1 to the Credit Agreement.
04/08/2024Date of transaction and Incremental Amendment No. 2 to the Credit Agreement; Date of the Warrantholders Agreement.
04/10/2024Date of signature of the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.